A CONCURRENT RESOLUTION encouraging the Cabinet for Health and Family Services and Medicaid managed care organizations to permit coverage of United States Food and Drug Administration approved digital therapeutics in order to provide more therapy options and improved compliance and outcomes for individuals going through substance use disorder recovery.
Bill status
in committee
3 of 5 stages cleared
Introduction
Feb 2021
Committee Review
Mar 2021
Senate Passage
Feb 2021
House Passage
Governor
Introduced Feb 3, 2021
Last action Mar 1, 2021
Floor votes · Senate Feb 26, 2021
How they voted
33–0
Passed · 2 other
Total votes 35
Feb 26, 2021
D
Democratic6
83% Yea
R
Republican29
96% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
10
Key actions
2
Committee
4
Mar 1, 2021
Committee
to Committee on Committees (H)
lower
Feb 26, 2021
Senate · Passed
Senate Vote: pass (33-0-2)
senate
Feb 24, 2021
Upper · Passed
reported favorably, 1st reading, to Consent Calendar
upper
Feb 9, 2021
Committee
to Health & Welfare (S)
upper
Feb 3, 2021
Committee
to Committee on Committees (S)
upper
Feb 3, 2021
Introduced
introduced in Senate
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Ralph Alvarado
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about SCR 61
Scope: KY
Hi! I can help you understand SCR 61. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline